Especially with the latest news, we should be much higher.
The company has proven that they are trying to be successful!
Facts are Facts!
Read it again!
SUNRISE, FL / ACCESSWIRE / March 17, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT), an emerging enterprise in the regenerative medicine / cellular therapy industry is pleased to announce, following the release of its Form 10-K Annual Report, key 2014 accomplishments including but not limited to:
1. A 2,040% increase in year over year revenues to $2.1 million in 2014 from $0.1 million in 2013.
2. A 28% decrease in year over year net loss to ($2.25) million in 2014 from ($3.14) million in 2013.
3. A 42% decrease in year over year cash used in operating activities to $1.1 million in 2014 from $1.9 million in 2013.
4. A 20% reduction ($2.3 million) in year over year current liabilities to $11.1 million at December 31, 2014 from $13.4 million at December 31, 2013.
5. A 20% reduction in the Company's working capital deficit.